USCAP Update On Hematopathology Classification: The International Consensus Classification Perspective 2023

Overview

The USCAP Update On Hematopathology Classification: The International Consensus Classification Perspective 2023 presents the latest developments in the diagnosis and classification of hematopoietic tumors. This course features content from developers of the International Consensus Classification (ICC) and compares it with the proposed 5th edition World Health Organization (WHO) classification, highlighting expanded clinical, morphologic, immunophenotypic, and molecular genetic criteria.

On-demand hematopathology education — accessible anytime, anywhere.

Format: Videos and PDFs

Original release date: November 17, 2023

Agenda

This course provides expert-led presentations and interactive microscopy sessions addressing multiple hematologic neoplasms and their classification. The agenda includes lectures on disease-specific topics as well as clinician perspectives to support practical implementation of new classifications.

• Small B-cell Neoplasms — Rebecca King, MD
• Lymphoplasmacytic Lymphoma, Myeloma and Related Neoplasms — James Cook, MD, PhD
• Cutaneous Lymphomas — John Goodlad, MD, MBChB, FRCPath
• Clinician Perspective on the Diagnosis of B-cell Lymphoma — Jane Winter, MD
• Aggressive B-cell Lymphomas — Elias Campo, MD, PhD
• Hodgkin Lymphoma and Grey Zone Lymphomas — Elias Campo, MD, PhD
• T-cell Lymphoma — Leticia Quintanilla-Fend, MD
• Molecular Approach to Malignant Lymphoma — Laurence de Leval, MD, PhD
• Clinician Perspective on the Diagnosis of T-cell Neoplasms — Steve Horwitz, MD
• Immunodeficiency-associated Lymphoproliferative Disorders — Elaine Jaffe, MD
• Histiocytic and Dendritic Cell Neoplasms — Elaine Jaffe, MD
• Acute Lymphoblastic Leukemia/Lymphoma and Acute Leukemias of Ambiguous Lineage — Michael Borowitz, MD, PhD
• Clonal Hematopoiesis and Myelodysplastic Syndromes — Robert Hasserjian, MD
• Myeloproliferative Neoplasms — Hans-Michael Kvasnicka, MD, PhD
• Mastocytosis — Attilio Orazi, MD, FRCPath
• Clinician Perspective on the Diagnosis of Eosinophilic and Mast Cell Disorders — Ayalew Tefferi, MD
• Myeloid/lymphoid Neoplasms with Eosinophilia and Tyrosine Kinase Gene Fusions — Sa Wang, MD
• Myelodysplastic/myeloproliferative Neoplasms — Attilio Orazi, MD, FRCPath
• Pediatric and/or Germline Disorders — Katherine Calvo, MD, PhD
• Acute Myeloid Leukemia — Daniel Arber, MD
• Clinician Perspective on the Diagnosis of Acute Myeloid Leukemia — Olatoyosi Odenike, MD
• Molecular Approach to Myeloid Disorders — Adam Bagg, MD

Speakers

• Rebecca King, MD
• James Cook, MD, PhD
• John Goodlad, MD, MBChB, FRCPath
• Jane Winter, MD
• Elias Campo, MD, PhD
• Leticia Quintanilla-Fend, MD
• Laurence de Leval, MD, PhD
• Steve Horwitz, MD
• Elaine Jaffe, MD
• Michael Borowitz, MD, PhD
• Robert Hasserjian, MD
• Hans-Michael Kvasnicka, MD, PhD
• Attilio Orazi, MD, FRCPath
• Ayalew Tefferi, MD
• Sa Wang, MD
• Katherine Calvo, MD, PhD
• Daniel Arber, MD
• Olatoyosi Odenike, MD
• Adam Bagg, MD

Target Audience

This course is designed for pathologists, hematopathologists, oncologists, hematologists, and other medical professionals involved in diagnosing and managing hematopoietic tumors who seek to update their knowledge on the latest classification standards and their practical application.

Why This Topic Matters

The USCAP Update On Hematopathology Classification: The International Consensus Classification Perspective 2023 addresses critical advances in hematopathology, focusing on standardized and updated tumor classification frameworks. Understanding these changes supports accurate diagnosis and informs therapeutic strategies in hematology and oncology.

As hematopathology continues to evolve rapidly, this course offered through MedHub Central reinforces essential expertise and confidence for clinicians and pathologists integrating the International Consensus Classification into clinical practice, enhancing professional capability in this specialized field.